In Li Miaomiao's view, the previous high dependence on Zheng Li in research and development was an abnormal phenomenon.
Science and technology innovation companies invest hundreds of billions of RMB in research and development every year, and in the past two years, this figure has exceeded 200 billion RMB.
The investment of human, financial, and material resources is not intended to foster dependence on Zheng Li among these researchers.
Li Miaomiao didn't want to put any pressure on Zheng Li, as Zheng Li had already made enough contributions to the early development of the Science and Technology Innovation Department.
"To solve this problem, we can take some marketing measures."
As Mr. Zhao just mentioned, marketing technology research and development is extremely difficult. Other companies have spent many years developing brain-computer interfaces before reaching the level of our first-generation brain-computer interface VR technology.
It is perfectly normal that our research and development on brain-computer interface VR technology has been slow.
We can then release some semi-finished products from the lab to boost morale.
Personally, I think that major technological breakthroughs in brain-computer interface technology every year or two should not become the norm.
Having worked in the smartphone industry before, I am very familiar with this. The concept of full-screen displays has been around since 2016, with various designs such as waterdrop screens, punch-hole screens, and notch screens emerging one after another.
It wasn't until 2021, five years later, that Xiaomi's Mix 4 achieved a true full-screen display in concept.
Brain-computer interface technology is far more difficult to develop than full-screen technology, not to mention that consumers still expect virtual reality.
The brain and computer interacting with each other is a level of difficulty that is somewhat beyond what normal technological advancements can achieve.
Instead of focusing on marketing, we should put more effort into the next-generation brain-computer interface VR that we are going to release this fall. It is actually a flagship VR with sufficient product strength.
Mr. Li, you don't need to feel too guilty.
The full-screen design of the Mi Mix 4 significantly damages the front-facing camera. Photos taken with the 20-megapixel front-facing camera on a true full-screen display are almost identical to those taken with a 1-megapixel camera.
After the vice president, who had been transferred from DaMi to serve as a senior executive since the establishment of Kechuang Future, finished speaking, everyone began to offer their advice.
What they said is true; the road to technological research and development is basically full of pitfalls with no clear path.
If you spend money and hear even a splash, you're lucky; more likely, you'll spend a lot of money only to find that the technology is not feasible.
"Okay, I understand what everyone means. I think I need some time to think about it carefully."
After Li Miaomiao finished speaking, she got up and left the meeting room.
She hadn't seen Zheng Li for a long time; since that incident, the frequency of her meetings with Zheng Li had gradually decreased.
However, when they were together, Zheng Li treated her the same as before, and then verbally said that the research and development had reached a critical moment and that she needed to take care of more business matters.
And recently, it's been almost a quarter since I've seen Zheng Li.
How should we evaluate the post-Zheng Li era of science and technology innovation in biotechnology? Is Li Miaomiao capable of shouldering this important responsibility?
This question was raised on Zhihu about a year ago. Later, as the market value of Kechuang Bio continued to decline, the question became a classic question and would be dug up and answered every now and then.
Each person's answer can be verified in the future to see if it was accurate.
"Thank you for the invitation. I am a member of an unknown supplier in the upstream of the science and technology innovation system, and also a minor shareholder of science and technology innovation biotechnology. We have certain interests in this relationship."
First of all, in the last three years, there is no doubt that the development of Kechuang Bio has not been as rapid as it was in the first five years.
There are various factors at play, but the most fundamental reason is that, unlike in the past three years when they were expected to produce groundbreaking products every year, these science and technology innovation companies have not produced any products that have impressed consumers or the industry.
According to sources within Kechuang Biotechnology, Zheng Li has devoted himself to the research and development of a key technology, the specifics of which are currently unknown.
There are various rumors circulating, ranging from virtual reality to cancer cures, but none of these rumors have been officially verified.
But thinking about it, it's normal. For such a crucial product, very few companies would release information before they succeed.
That was a digression; let's get back to the question itself.
In my opinion, the term "post-Zheng Li era" is inaccurate. The current Kechuang Biotechnology and other Kechuang-affiliated companies are still entirely controlled by Zheng Li; it is still the Zheng Li era.
Based on what I know, neither Kechuang Bio nor its core subsidiary Kechuang Future shows any signs of being gradually taken over by outsiders.
The so-called takeover of snow-capped mountains and grasslands circulating online has not yet been observed.
However, Zheng Li is not as efficient in scientific and technological research and development as before. It would have been abnormal for him to make technological breakthroughs every year.
Zheng Li lost his former magic, and after Zheng Li lost his magic, Kechuang Bio lost its former halo.
When General Manager Li came to our company for research before, I saw her from afar and she was indeed a natural beauty. From a management perspective, she didn't have any special features.
However, with Zheng Li around, simply avoiding mistakes would be the greatest achievement.
I think the pairing of Zheng Shen and President Li is quite reasonable.
It's probably not enough to say that he can shoulder the main responsibility. If, as this question suggests, the current science and technology innovation industry is entering the post-Zheng Li era, then I estimate that Li will be marginalized in less than six months.
From an investor's perspective, I believe that the valuation of Kechuang Bio has now reached a reasonable range.
When a stock is in a downward trend, everyone can only see its shortcomings and not its advantages.
My dear reader, there's more to this chapter! Please click the next page to continue reading—even more exciting content awaits!
Continue read on readnovelmtl.com
